William Keitel
Analyst · America
Thank you, Steve, and good afternoon, everyone. We have another quarter of record results to report today. We are pleased to be substantially raising our estimates for fiscal 2011 revenue and earnings per share. The impact related to the recent license dispute resolution announced today will be recorded in our second fiscal quarter and beyond. It is not reflected in our first fiscal quarter results. Our fiscal first quarter revenues of $3.35 billion were a record high, up 25% year-over-year and at the high end of our prior guidance. Non-GAAP earnings per share were also a record $0.82 per share, up 32% year-over-year, significantly exceeding the high end of our prior guidance. We shipped a record 118 million MSM chips during the quarter towards the high end of our prior guidance and average revenue per MSM increased sequentially consistent with our prior guidance. QCT's operating margin was 30%, driven by a favorable mix of smartphone chipsets. Total reported device sales by our licensees were a record $34 billion, exceeding our prior expectations and driven by a greater-than-expected mix of licensee device shipments in developed regions, notably North America, Japan and Korea. We estimate that our licensees shipped approximately 165 million to 169 million new CDMA devices in the September 2010 quarter, also a record. We estimate the average selling price of CDMA devices was approximately $201 to $207 per unit, up approximately 12% sequentially, driven by the greater mix of devices in developed regions, as well as approximately $8 of favorable foreign exchange. QTL's operating margin was 84% and the implied royalty rate that you calculate based on the information we provide was slightly lower sequentially, consistent with expectations and driven primarily by fixed revenue items and infrastructure royalties within QTL's total revenues. Cash and marketable securities totaled $19 billion at the end of the first quarter, including $6 billion onshore and $13 billion offshore. During the first fiscal quarter, we paid cash dividends of $309 million or $0.19 per share. And on January 14, we announced another cash dividend of $0.19 per share payable on March 25, 2011. Our non-GAAP tax rate was 19% in the first fiscal quarter. We recorded a $32 million tax benefit in the first quarter of fiscal 2011 related to fiscal 2010 as a result of the retroactive reenactment of the federal R&D tax credit. To facilitate a better period-to-period comparison, we excluded this tax benefit related to fiscal 2010 from our first quarter non-GAAP results. Our fiscal first quarter non-GAAP earnings per share were $0.10 higher than our initial guidance midpoint of $0.72 at the outset of the quarter. QCT was approximately $0.04 higher, QTL was approximately $0.03 higher. The remaining $0.03 was a combination of the lower tax rate driven by the fiscal 2011 portion of the federal R&D tax credit and investment gains not included in our prior guidance. We estimate that calendar 2010 CDMA device shipments were approximately 640 million to 660 million new devices. Based on the 650 million midpoint of our estimate, 2010 CDMA device shipments grew 28% year-over-year. Now turning to our guidance. We are increasing our estimate for calendar 2011 CDMA device shipments. We estimate that between 750 million and 800 million CDMA devices will ship in 2011, an increase of approximately 15% to 23% over the midpoint of our calendar 2010 estimate because I'm sure you know that we are substantially raising our financial guidance for the fiscal year. Of the $1.2 billion increase to our fiscal 2011 revenue guidance, approximately $650 million is driven by an improved outlook for our Chipset business and approximately $550 million is driven by an improved outlook in our Licensing business. The approximate $550 million licensing improvement is due in part to the license dispute resolution and in part to a material increase in the base Licensing business independent of the license resolution. The $550 million is also a net increase on top of the amount we included in our fiscal 2011 guidance back in November for the potential resolution of one or both of our licensee disputes. The new licensee amendment was just recently signed. Though the accounting treatment still needs to be finalized, we expect our fiscal second quarter will include revenues from this licensee, for sales in the second fiscal quarter, as well as for past sales in prior quarters. As Derek pointed out, we think that the implied royalty rate as you calculate it has become a less reliable metric for modeling the Licensing business. Having said that, we estimate that the implied rate for the remaining three quarters of fiscal 2011, excluding the amounts related to periods prior to the second fiscal quarter, will be relatively constant in the range of approximately 3.4% to 3.5%. As Derek noted, although we remain confident in our position, the arbitration with Panasonic may not be decided until after our fiscal year end, and we therefore are not forecasting any amounts related to any resolution with Panasonic in this fiscal year at this time. We expect non-GAAP fiscal 2011 revenues to be in the range of approximately$13.6 billion to $14.2 billion as compared to our prior estimate of $12.4 billion to $13 billion. We are also raising our fiscal 2011 earnings per share guidance by $0.28 per share. We anticipate non-GAAP earnings per share to be in the range of $2.91 to $3.05, an increase of 18% to 24% year-over-year. We estimate the average selling price of CDMA-based devices to be approximately $190 to $200 for all of fiscal 2011. In QCT, although the opportunity to be in the higher end of this range is now a bit better, reflecting stronger volume and mix expectations, we are reaffirming our prior estimate that operating margins will be in the range of 22% to 24% for fiscal 2011. The expected decrease in operating margins for the remainder of fiscal 2011 relative to the last couple of quarters reflects our continued expectation of a greater mix of mass-market smartphones and our new chipset products to service demand. We expect the combination of non-GAAP R&D and SG&A expense to increase approximately 12% year-over-year, higher than our prior guidance of approximately 7%, reflecting variable cost related to our greater expected revenues, as well as some foreign exchange impact. Based on the midpoint of our updated guidance, R&D expense will improve to approximately 17% of revenue, similar to the rate we experienced three and four years ago. And SG&A expense will improve to approximately 10% of revenue, the lowest rate in the last five years. We estimate our non-GAAP annual tax rate to be approximately 21%. Now turning to the second fiscal quarter, we estimate non-GAAP revenues to be in the range of approximately $3.45 billion to $3.75 billion. And non-GAAP earnings per share to be approximately $0.77 to $0.81. Based on the midpoints, we expect second quarter revenue and earnings per share to increase year-over-year by 35% and 34% respectively. We expect total reported device sales reported by our licensees to be approximately $36.5 billion to $38.5 billion, up 35% year-over-year based on the midpoint. We anticipate QCT shipments of approximately 113 million to 117 million MSM chips during the March quarter, down a bit coming off the busy holiday quarter but up 24% year-over-year based on the midpoint. We expect revenue per MSM to be down quarter-over-quarter driven by annual pricing resets with customers consistent with historical norms. And we expect lower operating margin sequentially. Our estimate for CDMA channel inventory is largely consistent with our prior expectations, remaining at the low end of the historical range through fiscal 2011. We anticipate second fiscal quarter non-GAAP R&D and SG&A expenses combined will increase approximately 11% sequentially, reflecting normal increased seasonal expenses primarily related to employee payroll taxes. Our fiscal second quarter non-GAAP earnings per share guidance midpoint is $0.03 lower as compared to our first quarter. We expect QTL to be better $0.17 sequentially, driven by revenue related to the new license dispute resolution and increased device volumes reported by licensees for the busy holiday quarter. We estimate that the one-time revenue benefit related to periods prior to the second fiscal quarter will be approximately $250 million or $0.09 per share in the second fiscal quarter. We expect QCT to be approximately $0.10 lower, driven by the seasonal lower volumes and pricing resets mentioned earlier. Non-GAAP combined R&D and SG&A expense growth accounts for approximately $0.05 and the remaining decrease is driven by the dilutive impact of increased share count and lower sequential investment income as we do not include estimates for uncertain realized investment gains losses in our forecast. Net unrealized gains on marketable securities were $968 million at the end of the first fiscal quarter. That concludes my comments. I will now turn the call back to Warren Kneeshaw.